Shengsuan Chemical Industry

Hebei Shengsuan Chemical Industry is a biotechnology and chemical manufacturing firm headquartered in Xingtai, Hebei Province, China. Established in 2018, the company focuses on the research, development, and production of a broad spectrum of fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). Their product portfolio prominently features high-demand peptide APIs such as Tirzepatide, Semaglutide, and Liraglutide, alongside traditional pharmaceutical reagents like Meropenem and Losartan potassium. The company operates multiple production bases in Hebei, Inner Mongolia, and Yunnan, and maintains technical collaborations with major Chinese universities to support product optimization. Shengsuan serves a global clientele across the pharmaceutical, healthcare, and agrochemical sectors as a specialized supplier and contract manufacturer.